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Raman spectroscopy (RS) is an optical technique that provides an objective method of pathological diagnosis based on the molecular
composition of tissue. Studies have shown that the technique can accurately identify and grade prostatic adenocarcinoma (CaP)
in vitro. This study aimed to determine whether RS was able to differentiate between CaP cell lines of varying degrees of biological
aggressiveness. Raman spectra were measured from two well-differentiated, androgen-sensitive cell lines (LNCaP and PCa 2b) and
two poorly differentiated, androgen-insensitive cell lines (DU145 and PC 3). Principal component analysis was used to study the
molecular differences that exist between cell lines and, in conjunction with linear discriminant analysis, was applied to 200 spectra to
construct a diagnostic algorithm capable of differentiating between the different cell lines. The algorithm was able to identify the cell
line of each individual cell with an overall sensitivity of 98% and a specificity of 99%. The results further demonstrate the ability of RS
to differentiate between CaP samples of varying biological aggressiveness. RS shows promise for application in the diagnosis and
grading of CaP in clinical practise as well as providing molecular information on CaP samples in a research setting.
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Prostate cancer is the most common cancer diagnosed in males
in the UK (Quinn et al, 2001). The gold standard technique for
diagnosing and characterising prostate cancer is currently histolo-
gical examination of prostate biopsy cores. The subjective nature
of this technique means that it is associated with considerable inter-
and intraobserver variation in reporting (Ozdamar et al, 1996;
Allsbrook et al, 2001). As the therapeutic options available to treat
prostate cancer increase, so does the importance of accurate
characterization of the tumour. For this reason, the development
of new technologies capable of providing accurate and objective
methods to assess prostate cancer is desirable.
Raman spectroscopy (RS) is an optical technique that utilises
molecular-specific, inelastic scattering of light photons to inter-
rogate biological material (Stone et al, 2002; Crow et al, 2003a).
When material is illuminated with laser light, a small fraction of
the photons are inelastically scattered by the intramolecular bonds
present. When this occurs, the photon donates energy to or
receives energy from the molecule, producing a change in the
molecule’s vibrational state. When it subsequently exits the
material, the light photon has an altered energy level and,
therefore, a different wavelength compared to the original laser
light. This change in the photon’s energy is known as the ‘Raman
shift’ and is measured in wavenumbers.
Photons interacting with different biochemical bonds undergo
specific Raman shifts, which considered together form the ‘Raman
spectrum’. The Raman spectrum is a plot of intensity against
Raman shift (Figure 1). The Raman spectrum is a direct function of
the molecular composition of the material studied. When applied
to biological tissue, the technique holds the potential to
differentiate between different pathologies based on the differences
in their biochemical makeup.
A study of prostatic core biopsies has shown that RS can identify
and grade prostatic adenocarcinoma (CaP) in vitro (Crow et al,
2003b), although the heterogeneity of prostatic pathology makes
prostatic tissue difficult to study. Cultured human prostatic cell
lines are the product of a monoclonal proliferation of immortalised
CaP cells. All cells within each cell line are theoretically identical,
making them easier to study than the heterogeneous prostatic
tissue. The aim of this study was to determine whether RS is able to
differentiate between cell lines representing CaPs of varying
biological aggressiveness. The study was undertaken with a view
to provide complimentary evidence to support the findings of the
prostate biopsy studies with a view to develop the technique for
application in clinical practise.
MATERIALS AND METHODS
Cell culture and preparation
Human prostate cancer cell lines (LNCaP, PC 3, DU145 and PCA
2b) were obtained from the European collection of Animal Cell
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Cultures Catalogue (ECACC) Porton Down, UK and grown in a
humidified 5% CO2 atmosphere at 371C according to the protocols
suggested by the ECACC. DU145, LNCaP and PC 3 cells were
maintained in RPMI 1640 tissue culture media (BioWhittakert)
with L-glutamine supplemented with 10% foetal calf serum (FCS),
penicillin (5000 IU ml1), streptomycin (5 mg ml1) and L-gluta-
mine (5 mg ml1) (growth media). MDApca2b cells were main-
tained in RPMI 1640 tissue culture media without L-glutamine
and without Phenol Red (Gibco, Paisley, UK) supplemented with
cholera toxin (62.5 ml), EGF (10 ng ml1), 0.05 mM phospho-
ethanolamine (25 ml) (100 pg ml1 hydrocortisone) 250 ml, 45 nM
selenious acid (1 ml), 0.005 mg ml1 insulin (22ml), penicillin
(5000 IU ml1), streptomycin (5 mg ml1) and 20% foetal bovine
serum (100 ml) (growth media). The cells were transported in low
serum RPMI 1640 tissue culture media (BioWhittakert) supple-
mented with 0.1% FCS, penicillin (5000 IU ml1), streptomycin
(5 mg ml1) and L-glutamine (5 mg ml1) (serum-free media).
Tissue culture plastics were obtained from Greiner Labortechnic
Ltd (Stonehouse, UK).
A limited number of prostate cancer cell lines are available and
the above four cell lines were selected as they can be considered
to present various stages in the development of androgen-
independent prostate cancer and of biological aggression. LNCaP
(Horoszewicz et al, 1983) and MDApca2b (Navone et al, 1997) cells
can be considered relatively well-differentiated cells, which retain
androgen sensitivity, whereas DU145 (Mickey et al, 1980) and PC 3
(Kaighn et al, 1979) cells are more poorly differentiated cells,
which no longer posses androgen sensitivity and show more
aggressive phenotypic features such as increased migration and
invasiveness (Lang et al, 2000; Fisher et al, 2002).
To be suitable for analysis by the Raman system, the cells
required transfer to a calcium fluoride slide. Cells were seeded in
a T-75 tissue culture flask at a density of 1 106 cells ml1 and
grown to 80% confluence in growth media as described above. The
growth media were then aspirated and replaced with 10 ml serum-
free media and the cells were incubated for a further 24 h. The cells
were scrapped free from their culture dish using a cell scraper
(GrienerBio-one), transferred to a 20 ml universal tube and
centrifuged at 2000 r.p.m. for 10 min at room temperature. Trypsin
was avoided to minimise contamination of the samples. The
supernatant was aspirated and the cells were resuspended in
phosphate-buffered saline (PBS) (Oxoid BR14) to wash the
remaining media off the cells. The cells were then centrifuged
for 10 min at 2000 r.p.m. for a second time. The supernatant was
then aspirated and the cells put through a cytospin centrifuge
cycle at 1250 r.p.m. for 5 min, placing the cells directly onto a
calcium fluoride slide. The slide was kept in a moist environment
and taken back to the spectroscopy lab, so that spectra could be
measured from the cells, within 30 min of removal from the
culture medium.
Raman spectroscopy
The Raman system (Figure 2) comprises a 300 mW laser
(Renishaw) that supplies near-infrared excitation light at 830 nm,
which is focused onto the sample via a microscope objective (Leica
NPLAN  50 objective). The same objective collects the scattered
light from the sample and directs it to the spectrometer. The
spectrometer processes this scattered light, by rejecting the
unwanted portion and separating the remainder into its constitu-
ent wavelengths. The Raman spectrum is recorded on a deep
depletion charge-coupled device detector (Renishaw RenCam).
The system has been customised in order to produce the optimal
set-up for recording Raman spectra from biological tissue in vitro
(Stone, 2001). The recorded Raman spectrum is digitalised and
displayed on a personal computer using GRAMS/32 software
(Galactic Industries). The system is managed using Renishaw
WiRE software (Windows based Raman Environment Version
1.3.15), which allows the experimental parameters to be set.
In all, 50 Raman spectra were recorded from DU 145 cells and
LNCaP cells, with 49 and 51 spectra recorded from MDApca2b and
PC 3 cells, respectively. Each spectrum was acquired over a period
of 20 s.
Construction and testing of the diagnostic algorithm
The Raman spectra were analysed with the aim of determining
whether there were consistent differences between the molecular
composition of the different cell lines and whether these
differences would allow for construction of a diagnostic algorithm
capable of identifying the cell line of an individual cell from its
Raman spectrum. The algorithms were created using principal
component fed (PCA/LDA) as described below. This spectral
analysis was carried out using tailor-made routines run in the
MATLABs environment and the Eigenvectors PLS-toolbox.
Principal component analysis was used to compress the
information held by the spectra (Jackson, 1991) and involved
calculating 25 principal components (also known as loads) that
describe the greatest variance of the spectral data from its mean.
Each spectrum can be reconstructed by adding the products of the
loads and the scores for each spectrum. The scores are effectively
the amount of each component found in the spectrum. Therefore,
so long as the loads are known, the spectra in the data set can be
described by the 25 scores. The first three principal components
were visually analysed to determine whether there were differences
in the concentration of specific species of molecules present in
each cell line. The degree of separation achieved between the
different cell lines was initially determined using PCA alone.
Subsequently, LDA was also employed to accentuate the separation
between cell lines (Ramanujam et al, 1996; Otto, 1999) in order to
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Figure 1 A Raman spectrum from a prostate cell with wavenumbers
labelled for major peaks.
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Figure 2 Renishaw 1000 Raman system.
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increase the diagnostic accuracy of the algorithm. This was
achieved by applying three linear discriminant functions (LDFs) to
each of the spectra.
The accuracy of the algorithm, in correctly identifying a cell’s
identity from its spectrum, was determined using ‘leave one
spectrum out’ crossvalidation. This involved removing one
spectrum from the data set and constructing a diagnostic
algorithm from the remainder of the spectra. The algorithm then
predicted the cell line of ‘left out’ spectrum and stored the result.
This process was repeated, with each spectrum left out in turn,
until each of the spectra had its cell line predicted. The overall
predictive accuracy of the algorithm was calculated and expressed
in terms of sensitivity and specificity for each cell line.
RESULTS
Using the methods outlined above, good quality Raman spectra
were measured from each of the cell lines studied. Figure 3 shows
the mean Raman spectra measured from each of the four cell lines.
In the interest of clarity, the spectra have been equally spaced with
respect to the intensity axis utilising the 1450 peak as a reference
point. Although the spectra appear similar in shape, subtle
morphological differences exist. These differences were exploited
by calculating the principal components of the spectral data set.
The first three principal components, that is, those that describe
the greatest variance in the spectral data set, are shown in Figure 4.
Visual analysis of these principal components allows identification
of molecular species from their Raman peaks. The principal
components have peaks and troughs that can be identified from
the literature to provide an understanding of the origins of the
statistical variations. It is the concentrations of these molecular
species that vary most significantly between the four cell lines.
Principal component 1 (PC1) represents increased concentra-
tions of nuclear acids (721, 783, 1305, 1450 and 1577 cm1), DNA
backbone (O –P –O) (827 and 1096 cm1) and unordered proteins
(1250 and 1658 cm1). Principal component 2 (PC2) represents
decreased concentrations of a-helix proteins (935, 1263 and
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1657 cm1) and phospholipids (719, 1094, 1125 and 1317 cm1).
Principal component 3 (PC3) represents decreased concentrations
of lipids (1090, 1302 and 1373 cm1), glycogen (484 cm1) and
nucleic acids (786, 1381 and 1576 cm1).
Cell lines DU145 and PC 3 are androgen insensitive and can be
discriminated when the scores for PC3 are high and the scores for
PC2 less than or equal to zero. This is in contrast to the androgen-
sensitive cell lines of MDApca2b and LnCaP, which can be
discriminated with PC3 scores of zero or less and PC2 scores of
zero or greater.
A good separation between the four cell lines can be achieved
by utilising just the first three PCs. A three-dimensional scatter
plot of the principal components scores (the amount of each
spectral component found in each spectrum measured) is shown in
Figure 5. This significantly strengthens the view that there is an
inherent molecular difference between the cells, by providing a
display of the natural separation of the data without supervised
statistical manipulation. Cell line DU145 appears to have a
distinctly lower level of nuclear material and unordered proteins
when compared to the other cell lines, as represented by PC1.
Figure 6 illustrates the degree of separation that the PCA/LDA
algorithm achieved between the spectra of each cell line. The
position of each spectrum is plotted in three-dimensional space
relative to each of its three LDFs. It can be seen that there is
excellent clustering of spectra within each cell line group, with
each of the four cell line groups occupying a distinct region of the
three-dimensional plot space.
Table 1 gives the crossvalidated results achieved by the
algorithm. The rows of the table show the numbers of spectra
measured for each cell line. The columns of the table show the
number of spectra that the algorithm has predicted as belonging to
each cell line. By looking across each row of the table, the number
of correctly predicted spectra for each cell line, shown in bold, can
be seen. The remaining values within each row represent
misclassifications by the algorithm. Figure 7 illustrates these data
in bar chart form. The X-axis represents true cell line and the
Z-axis represents Raman predicted cell line, with the Y-axis
displaying the percentage of spectra predicted into each cell line.
The diagonal row of large bars shows correct predictions by the
algorithm, with all other bars representing misclassifications.
Table 2 shows how these results translate into sensitivities and
specificities for the prediction of each of the four cell lines.
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Figure 5 A three-dimensional scatter plot of the scores of PCs 1, 2 and
3. This demonstrates the natural clustering of the four cell lines spectra,
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Figure 7 A bar chart demonstrating the prediction power of the
diagnostic algorithm.
Table 1 Crossvalidated results achieved by the diagnostic algorithm
Raman prediction
DU145 PC3 LNCaP pca2b
Confirmed histology
DU145 49 1 0 0
PC3 1 49 1 0
LNCaP 0 0 49 1
pca2b 0 0 0 49
Table 2 Sensitivities and specificities achieved by the diagnostic
algorithm
DU145 (%) PC3 (%) LNCaP (%) pca2b (%)
Sensitivity 98 96 98 100
Specificity 100 99 99 99
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DISCUSSION
The results of the PCA taken alone begin to give insight as to the
types of molecules that vary in concentration between CaP cell
lines of differing biological aggressiveness. These variations are
complex, making it difficult to form a complete picture as to their
nature; however, the major variations are documented in the
results. In a previous Raman study, CaP was found to have a
reduced concentration of glycogen and increased concentration
of nucleic acids compared to benign prostatic hyperplasia (Crow
et al, 2003b). The results of the current study suggest that lower
glycogen concentrations are found in poorly differentiated cell
lines (DU145 and PC3) compared to the better differentiated cell
lines (MDApca2b and LnCaP). The picture with nucleic acids is
less clear with the androgen-independent cell lines, if anything,
showing lower concentrations of nucleic acids than androgen-
dependent cell lines. Interpretation of the spectra and principal
components remains imprecise and qualitative in nature; however,
work is ongoing to devise an accurate method by which to retrieve
quantitative molecular information.
The PCA/LDA algorithm achieved near perfect identification
of each cell line, with sensitivities ranging from 96 to 100% and
specificities all 99% or higher. These results confirm that RS is able
to differentiate between cells derived from CaPs of different
biological aggressiveness.
These findings suggest that RS may have potential application
as a research tool. Within the field of cell culture, for example,
when cells undergo apoptosis, the DNA content of the cell is
reduced and flow cytometry is currently used to quantify apoptosis
by measuring the DNA content of cells (Darzynkiewicz et al, 2001).
As RS exploits biochemical differences between cells, an algorithm
could be generated to identify apoptotic cells based on the change
in their Raman spectrum as the DNA content diminishes.
This study also has implications for clinical practise. The results
reinforce previous studies, which have suggested that RS can be
used to grade CaP (Crow et al, 2003b). Given the high degree of
accuracy and objectivity achieved, these findings strongly support
the development of RS as a tool capable of assisting pathologists in
accurately assessing prostatic tissue. Prior to the widespread use of
core biopsy, many CaPs were diagnosed using prostatic fine-needle
aspiration (FNA). Core biopsy has superseded FNA, largely
because histological examination of prostatic core biopsies is able
to provide more accurate prognostic information than cytological
examination of prostatic FNA samples (Schmidt, 1992). The results
achieved by this study demonstrate that RS may have utility
analysing prostate FNA samples with the potential to derive
prognostic information.
Whether applied to analyse prostate biopsies or FNA samples,
the high speed, accuracy and objectivity of RS means that it shows
promise in improving the clinical diagnosis of CaP.
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